Vanguard Global Advisers, LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1811242
MALVERN, PA
Position in ADPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
15,983
-0.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Vanguard Global Advisers, LLC holds $1,244,898,778 across 35 Diagnostics & Research names. ADPT ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
801,663 | $401,921,761 | |
| 2 | DHR |
Danaher Corp /De/
|
1,359,015 | $258,865,177 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
170,040 | $89,515,857 | |
| 4 | A |
Agilent Technologies, Inc.
|
609,101 | $80,906,885 | |
| 5 | WAT |
Waters Corp /De/
|
211,870 | $79,459,724 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
359,846 | $69,529,444 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
43,604 | $55,704,546 | |
| 8 | DGX |
Quest Diagnostics Inc
|
240,742 | $51,025,266 |
All Filings in ADPT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 63,932 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | — | 64,172 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||